Neil F. McFarlane, CEO of Zevra Therapeutics ZVRA, has filed 0 purchases and 5 sales on the open market. Over the past 12 months that comes to a net sale of $1.2M. The latest trade was on 02/09.

NM

NM

Neil F. McFarlane

President and CEO

Company

Zevra Therapeutics ZVRA

First filing

23/05/19

Trades

22 trades

Buys / sales

0 / 5

12-month net buying

−$1.2M

Last trade

02/09

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Zevra TherapeuticsZVRA	Open-market sale10b5-1 plan	02/09	02/10	14,625 sh	$8.56	$125,190	−3.6%
Zevra TherapeuticsZVRA	Open-market sale10b5-1 plan	02/02	02/02	91,000 sh	$9.38	$853,580	−20.0%
Zevra TherapeuticsZVRA	Open-market sale10b5-1 plan	25/10/10	25/10/10	19,500 sh	$10.82	$210,990	−8.1%
Zevra TherapeuticsZVRA	Open-market sale10b5-1 plan	25/02/13–25/02/14	25/02/14	91,817 sh2 trades	$7.92avg.	$727,484.98	−32.4%